Search

everythinglearnresearchcommunity

for

Search:↓

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

A woman's new seizures were caused by a brain tumor likely linked to her past cancer treatment, and choosing safe seizure medications is important for women who can have children.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib, a hair regrowth treatment, may worsen acne.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.